Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 70 or older who are considered unfit or frail
- People who have at least one tumour that can be measured on a scan, with the largest measurable tumour being at least 15 mm in size
- People who have been diagnosed with a type of lymphoma called DLBCL (confirmed by a tissue biopsy), who have not yet received any treatment for it
- People who are expected to live for more than 3 months
- People whose heart, liver, kidneys, and lungs are functioning at an adequate level as defined by specific test results (confirm specific thresholds with the trial site)
- People whose blood counts — including red blood cells, platelets, and white blood cells — meet minimum levels set by the trial (confirm specific values with the trial site)
- People who are able to understand the study and are willing to sign a written consent form
- People who are able to have children and are willing to use reliable contraception from the time of enrolment through the follow-up period of the study
Who may not be able to join:
- People with severely reduced liver or kidney function, based on specific blood test results
- People with a significant heart condition or serious irregular heartbeat that causes symptoms or affects heart function
- People with an active infection that is not under control
- People who have another cancer that currently requires treatment
- People whose DLBCL has spread to the brain or spinal cord
- People who currently need, or are expected to need, steroid medication taken throughout the body (such as tablets or injections)
- People who have a current or past history of blood clots in blood vessels
- People with psychological or mental health conditions that would prevent them from taking part in or consenting to the study
- People who, in the opinion of the trial doctor, are unlikely to be able to complete all required visits and procedures
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Zhengming Jin, The First Affiliated Hospital of Soochow University
Phone: 67781856
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Complete response rate(CRR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.